How Supplied Proair HFA (albuterol sulfate) Inhalation Aerosol is supplied as a pressurized aluminum canister with a red plastic actuator with a dose counter and white dust cap each in boxes of one.
In Teva Branded Pharm. Prods. R&D v. Amneal Pharms. of N.Y., LLC, the US District Court for the District of New Jersey ordered Teva to delist five patents from the Food and Drug Administration (FDA)’s ...
Dec 20 (Reuters) - Teva Pharmaceuticals (TEVA.TA), opens new tab failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ProAir HFA inhaler ...
On June 10, 2024, Judge Stanley R. Chesler of the United States District Court for the District of New Jersey granted the Amneal defendants’ motion for partial judgment on their counterclaims in a ...
The Food and Drug Administration recently approved Amphastar’s albuterol sulfate inhalation aerosol, previously known as AMP-008. This product is for the treatment or prevention of bronchospasm in ...
When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC) isn’t backing down. After filing a challenge in November against more than 100 patents in the FDA’s Orange Book—and ...
Time is running out for patients who use albuterol inhalers to replace those propelled by chlorofluorocarbons (CFCs) with ones that rely on eco-friendly hydrofluoroalkane (HFA). After December 31, ...
The U.S. Food and Drug Administration recently issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane or HFA-propelled albuterol ...
Detailed price information for Amneal Pharmaceuticals Inc (AMRX-Q) from The Globe and Mail including charting and trades.
WASHINGTON (Reuters) - U.S. patients who use certain asthma inhalers made with ozone-depleting propellants should talk to their doctors now about alternatives ahead of a ban that starts in January, ...
Albuterol sulfate inhalation aerosol is indicated for the treatment or prevention of bronchospasm in adults and children 12 years of age and older with reversible obstructive airway disease. Kone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results